Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Onychomycosis: current treatment options.

Ellen Davis Jones1

  • 1Adult/Gerontological Nurse Practitioner Program, University of North Carolina at Greensboro, USA. ellen_jones@uncg.edu

Journal of the American Academy of Nurse Practitioners
|April 29, 2003
PubMed
Summary

Onychomycosis treatment is crucial for patients with chronic illnesses like diabetes, as it impacts mobility and blood flow. Primary care should prioritize managing this fungal infection for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reminiscence therapy for older women with depression. Effects of nursing intervention classification in assisted-living long-term care.

Journal of gerontological nursing·2003
Same author

The use of reminiscence therapy for the treatment of depression in rural-dwelling older adults.

Issues in mental health nursing·2002
See all related articles

Area of Science:

  • Dermatology
  • Podiatry
  • Infectious Diseases

Background:

  • Onychomycosis is frequently viewed as a cosmetic issue.
  • Treatment decisions often hinge on patient cost and adherence.
  • Chronic illnesses can complicate onychomycosis management.

Observation:

  • Onychomycosis in patients with diabetes and peripheral vascular disease is not merely cosmetic.
  • Untreated onychomycosis can reduce mobility and impair blood flow to digits.
  • Evidence supports the necessity of treating onychomycosis in vulnerable populations.

Findings:

  • Current evidence highlights the importance of treating onychomycosis in individuals with chronic conditions.
  • Management requires careful consideration of patient-specific factors and treatment efficacy.
  • Onychomycosis poses significant risks beyond aesthetics for those with chronic illnesses.

Implications:

  • Primary care clinicians must integrate onychomycosis treatment into chronic disease management plans.
  • Recognizing the clinical significance of onychomycosis is vital for patient care.
  • Prompt and appropriate treatment can prevent complications and improve quality of life.

Related Experiment Videos